[1] Fitzmaurice C, Dicker D, Pain A, et al.  The global burden of cancer 2013[J]. JAMA Oncol, 2015, 1(4): 505-527.   doi: 10.1001/jamaoncol.2015.0735
[2] Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.   doi: 10.3322/caac.21492
[3] Cao JX, Wang YM, Kong XQ, et al.  Good interrater reliability of a new grading system in detecting traumatic bone marrow lesions in the knee by dual energy CT virtual non-calcium images[J]. Eur J Radiol, 2015, 84(6): 1109-1115.   doi: 10.1016/j.ejrad.2015.03.003
[4] Mileto A, Nelson RC, Samei E, et al.  Impact of dual-energy multi-detector row CT with virtual monochromatic imaging on renal cyst pseudoenhancement: in vitro and in vivo study[J]. Radiology, 2014, 272(3): 767-776.   doi: 10.1148/radiol.14132856
[5] Dalbeth N, House ME, Aati O, et al.  Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study[J]. Ann Rheum Dis, 2015, 74(5): 908-911.   doi: 10.1136/annrheumdis-2014-206397
[6] Shi JW, Dai HZ, Shen L, et al.  Dual-energy CT: clinical application in differentiating an adrenal adenoma from a metastasis[J]. Acta Radiol, 2014, 55(4): 505-512.   doi: 10.1177/0284185113501660
[7] Sun X, Shao XD, Chen HS.  The value of energy spectral CT in the differential diagnosis between benign and malignant soft tissue masses of the musculoskeletal system[J]. Eur J Radiol, 2015, 84(6): 1105-1108.   doi: 10.1016/j.ejrad.2015.02.028
[8] Johnson TRC.  Dual-energy CT: general principles[J]. AJR Am J Roentgenol, 2012, 199(5S): S3-8.   doi: 10.2214/AJR.12.9116
[9] Thaiss WM, Sauter AW, Bongers M, et al.  Clinical applications for dual energy CT versus dynamic contrast enhanced CT in oncology[J]. Eur J Radiol, 2015, 84(12): 2368-2379.   doi: 10.1016/j.ejrad.2015.06.001
[10] Goo HW, Goo JM.  Dual-energy CT: new horizon in medical imaging[J]. Korean J Radiol, 2017, 18(4): 555-569.   doi: 10.3348/kjr.2017.18.4.555
[11] Faby S, Kuchenbecker S, Sawall S, et al.  Performance of today's dual energy CT and future multi energy CT in virtual non-contrast imaging and in iodine quantification: a simulation study[J]. Med Phys, 2015, 42(7): 4349-4366.   doi: 10.1118/1.4922654
[12] Knöß N, Hoffmann B, Krauss B, et al.  Dual energy computed tomography of lung nodules: differentiation of iodine and calcium in artificial pulmonary nodules in vitro[J]. Eur J Radiol, 2011, 80(3): e516-e519.   doi: 10.1016/j.ejrad.2010.11.001
[13] Hou WS, Wu HW, Yin Y, et al.  Differentiation of lung cancers from inflammatory masses with dual-energy spectral CT imaging[J]. Acad Radiol, 2015, 22(3): 337-344.   doi: 10.1016/j.acra.2014.10.004
[14] Li M, Zheng XP, Li JY, et al.  Dual-energy computed tomography imaging of thyroid nodule specimens: comparison with pathologic findings[J]. Invest Radiol, 2012, 47(1): 58-64.   doi: 10.1097/RLI.0b013e318229fef3
[15] Chae EJ, Song JW, Seo JB, et al.  Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience[J]. Radiology, 2008, 249(2): 671-681.   doi: 10.1148/radiol.2492071956
[16] Winer-Muram HT.  The solitary pulmonary nodule[J]. Radiology, 2006, 239(1): 34-49.   doi: 10.1148/radiol.2391050343
[17] Chae EJ, Song JW, Krauss B, et al.  Dual-energy computed tomography characterization of solitary pulmonary nodules[J]. J Thorac Imaging, 2010, 25(4): 301-310.   doi: 10.1097/RTI.0b013e3181e16232
[18] Kawai T, Shibamoto Y, Hara M, et al.  Can dual-energy CT evaluate contrast enhancement of ground-glass attenuation? phantom and preliminary clinical studies[J]. Acad Radiol, 2011, 18(6): 682-689.   doi: 10.1016/j.acra.2010.12.014
[19] Zhang Y, Tang J, Xu JR, et al.  Analysis of pulmonary pure ground-glass nodule in enhanced dual energy CT imaging for predicting invasive adenocarcinoma: comparing with conventional thin-section CT imaging[J]. J Thorac Dis, 2017, 9(12): 4967-4978.   doi: 10.21037/jtd.2017.11.04
[20] Jepperson MA, Cernigliaro JG, Ibrahim ESH, et al.  In vivo comparison of radiation exposure of dual-energy CT versus low-dose CT versus standard CT for imaging urinary calculi[J]. J Endourol, 2015, 29(2): 141-146.   doi: 10.1089/end.2014.0026
[21] Ogawa M, Hara M, Imafuji A, et al.  Dual-energy CT can evaluate both hilar and mediastinal lymph nodes and lesion vascularity with a single scan at 60 seconds after contrast medium injection[J]. Acad Radiol, 2012, 19(8): 1003-1010.   doi: 10.1016/j.acra.2012.03.024
[22] Liu XW, Ouyang D, Li H, et al.  Papillary thyroid cancer: dual-energy spectral CT quantitative parameters for preoperative diagnosis of metastasis to the cervical lymph nodes[J]. Radiology, 2014, 275(1): 167-176.   doi: 10.1148/radiol.14140481
[23] Liu HH, Yan FH, Pan ZL, et al.  Evaluation of dual energy spectral CT in differentiating metastatic from non-metastatic lymph nodes in rectal cancer: initial experience[J]. Eur J Radiol, 2015, 84(2): 228-234.   doi: 10.1016/j.ejrad.2014.11.016
[24] Tawfik AM, Razek AA, Kerl JM, et al.  Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes[J]. Eur Radiol, 2014, 24(3): 574-580.   doi: 10.1007/s00330-013-3035-3
[25] Li XB, Meng XY, Ye ZX.  Iodine quantification to characterize primary lesions, metastatic and non-metastatic lymph nodes in lung cancers by dual energy computed tomography: an initial experience[J]. Eur J Radiol, 2016, 85(6): 1219-1223.   doi: 10.1016/j.ejrad.2016.03.030
[26] Choi H, Charnsangavej C, Faria SC, et al.  Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria[J]. J Clin Oncol, 2007, 25(13): 1753-1759.   doi: 10.1200/JCO.2006.07.3049
[27] Kim YN, Lee HY, Lee KS, et al.  Dual-energy CT in patients treated with anti-angiogenic agents for non-small cell lung cancer: new method of monitoring tumor response?[J]. Korean J Radiol, 2012, 13(6): 702-710.   doi: 10.3348/kjr.2012.13.6.702
[28]

顾圣佳. 双能量CT成像在非小细胞肺癌非手术治疗疗效评估中的应用研究[D]. 上海: 上海交通大学, 2015.

Gu SJ. The study of quantitative therapy response assessment of non-small cell lung cancer with dual-energy computed tomography[D]. Shanghai: Shanghai Jiao Tong University, 2015.

[29] Sun YS, Zhang XY, Cui Y, et al.  Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer[J]. Chin J Cancer Res, 2013, 25(6): 722-728.   doi: 10.3978/j.issn.1000-9604.2013.12.01
[30] Chae EJ, Kim N, Seo JB, et al.  Prediction of postoperative lung function in patients undergoing lung resection: dual-energy perfusion computed tomography versus perfusion scintigraphy[J]. Invest Radiol, 2013, 48(8): 622-627.   doi: 10.1097/RLI.0b013e318289fa55
[31] Bahig H, Campeau MP, Lapointe A, et al.  Phase 1-2 study of dual-energy computed tomography for assessment of pulmonary function in radiation therapy planning[J]. Int J Radiat Oncol Biol Phys, 2017, 99(2): 334-343.   doi: 10.1016/j.ijrobp.2017.05.051